Satsuma Pharmaceuticals Inc. (STSA) NASDAQ
$4.25 -0.05 (-1.16%)
Market Cap: $135.65M
As of 06/28/22 04:00 PM EDT. Market closed.
Satsuma Pharmaceuticals Inc. (STSA) NASDAQ
$4.25 -0.05 (-1.16%)
Market Cap: $135.65M
As of 06/28/22 04:00 PM EDT. Market closed.
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product candidate for the acute treatment of migraine. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be quickly and easily self-administered with a proprietary pre-filled, single-use, ... read more
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic product candidate for the acute treatment of migraine. Its product candidate, STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, or DHE, which is designed to be quickly and easily self-administered with a proprietary pre-filled, single-use, nasal delivery device. DHE products have long been recommended as a first-line therapeutic option for the acute treatment of migraine and have significant advantages over other therapeutics for many patients. However, broad use has been limited by invasive and burdensome administration and/or sub-optimal clinical performance of available injectable and liquid nasal spray products. STS101 is in Phase 3 development and specifically designed to deliver the clinical advantages of DHE while overcoming these shortcomings. read less
COMPANY PROFILE
Sector
Industry
CEO
John Kollins
Full Time Employees
19
URL
Address
400 Oyster Point Blvd Ste 221, California, South San Francisco, 94080-1952.
Sector
Industry
CEO
John Kollins
Full Time Employees
19
URL
Address
400 Oyster Point Blvd Ste 221, California, South San Francisco, 94080-1952.
PRICE CHART
From:
To:
NEWS
KEY STATS
Open
$4.38
Previous Close
$4.30
Days Range
$4.20 - $4.54
52 week range
$2.51 - $7.46
Volume
17,563
Avg. Volume (30 days)
102,119
Market Cap
$135.65M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
31,545,564
Open
$4.38
Previous Close
$4.30
Days Range
$4.20 - $4.54
52 week range
$2.51 - $7.46
Volume
17,563
Avg. Volume (30 days)
102,119
Market Cap
$135.65M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
31,545,564
Open in:
Open in:
INSIDER TRANSACTIONS FOR SATSUMA PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| COMMODORE CAPITAL LP | 10% Owner | Nov 24, 2021 | Buy | $5.42 | 2,922 | 15,837 | 3,711,286 | Nov 29, 2021, 04:30 PM |
| COMMODORE CAPITAL LP | 10% Owner | Nov 22, 2021 | Buy | $5.49 | 9,979 | 54,785 | 3,708,364 | Nov 23, 2021, 04:30 PM |
| COMMODORE CAPITAL LP | 10% Owner | Nov 19, 2021 | Buy | $5.44 | 3,225 | 17,544 | 3,698,385 | Nov 23, 2021, 04:30 PM |
| COMMODORE CAPITAL LP | 10% Owner | Nov 11, 2021 | Buy | $6.05 | 7,941 | 48,043 | 3,695,160 | Nov 12, 2021, 04:31 PM |
| COMMODORE CAPITAL LP | 10% Owner | Nov 10, 2021 | Buy | $5.85 | 9,622 | 56,289 | 3,687,219 | Nov 12, 2021, 04:31 PM |
| COMMODORE CAPITAL LP | 10% Owner | Nov 08, 2021 | Buy | $5.99 | 560 | 3,354 | 3,677,597 | Nov 10, 2021, 04:30 PM |
| COMMODORE CAPITAL LP | 10% Owner | Nov 05, 2021 | Buy | $5.95 | 7,800 | 46,410 | 3,677,037 | Nov 08, 2021, 04:33 PM |
| COMMODORE CAPITAL LP | 10% Owner | Nov 04, 2021 | Buy | $5.88 | 1,400 | 8,232 | 3,669,237 | Nov 08, 2021, 04:33 PM |
| COMMODORE CAPITAL LP | 10% Owner | Nov 02, 2021 | Buy | $5.64 | 8,880 | 50,083 | 3,667,837 | Nov 04, 2021, 04:31 PM |
| COMMODORE CAPITAL LP | 10% Owner | Oct 29, 2021 | Buy | $5.71 | 44,651 | 254,957 | 3,658,957 | Nov 02, 2021, 04:30 PM |
| COMMODORE CAPITAL LP | 10% Owner | Oct 28, 2021 | Buy | $5.55 | 15,082 | 83,705 | 3,614,306 | Oct 29, 2021, 04:30 PM |
| COMMODORE CAPITAL LP | 10% Owner | Oct 27, 2021 | Buy | $5.45 | 39,581 | 215,716 | 3,599,224 | Oct 29, 2021, 04:30 PM |
| COMMODORE CAPITAL LP | 10% Owner | Oct 22, 2021 | Buy | $5.51 | 27,629 | 152,236 | 3,559,643 | Oct 25, 2021, 04:31 PM |
| COMMODORE CAPITAL LP | 10% Owner | Oct 21, 2021 | Buy | $5.40 | 32,816 | 177,206 | 3,532,014 | Oct 25, 2021, 04:31 PM |
| COMMODORE CAPITAL LP | 10% Owner | Oct 20, 2021 | Buy | $5.44 | 40,663 | 221,207 | 3,499,198 | Oct 21, 2021, 04:30 PM |
| COMMODORE CAPITAL LP | 10% Owner | Oct 19, 2021 | Buy | $5.07 | 87,580 | 444,031 | 3,458,535 | Oct 21, 2021, 04:30 PM |
| COMMODORE CAPITAL LP | 10% Owner | Oct 18, 2021 | Buy | $4.87 | 36,194 | 176,265 | 3,370,955 | Oct 19, 2021, 05:13 PM |
| COMMODORE CAPITAL LP | 10% Owner | Oct 15, 2021 | Buy | $4.83 | 126,000 | 608,580 | 3,334,761 | Oct 19, 2021, 05:13 PM |
| RA CAPITAL MANAGEMENT, L.P. | Director | Feb 26, 2021 | Buy | $5.68 | 1,232,394 | 6,999,998 | 5,155,854 | Mar 02, 2021, 04:30 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Sep 01, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 21,212 | Sep 03, 2020, 04:06 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Sep 01, 2020 | Sale | $22.21 | 1,000 | 22,210 | 20,212 | Sep 03, 2020, 04:06 PM |
| O'Neil Thomas P. | Chief Financial Officer | Sep 01, 2020 | Option Exercise | $4.56 | 750 | 3,420 | 750 | Sep 03, 2020, 04:05 PM |
| O'Neil Thomas P. | Chief Financial Officer | Sep 01, 2020 | Sale | $22.19 | 750 | 16,645 | 0 | Sep 03, 2020, 04:05 PM |
| O'Neil Thomas P. | Chief Financial Officer | Aug 05, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 1,000 | Aug 07, 2020, 06:40 PM |
| O'Neil Thomas P. | Chief Financial Officer | Aug 05, 2020 | Sale | $25.00 | 1,000 | 25,000 | 0 | Aug 07, 2020, 06:40 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Aug 03, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 21,012 | Aug 05, 2020, 04:03 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Aug 03, 2020 | Sale | $22.91 | 1,000 | 22,906 | 20,212 | Aug 05, 2020, 04:03 PM |
| O'Neil Thomas P. | Chief Financial Officer | Jul 01, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 394 | Jul 02, 2020, 04:15 PM |
| O'Neil Thomas P. | Chief Financial Officer | Jul 01, 2020 | Sale | $26.65 | 1,000 | 26,654 | 0 | Jul 02, 2020, 04:15 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Jul 01, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 20,812 | Jul 02, 2020, 04:13 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Jul 01, 2020 | Sale | $26.68 | 1,000 | 26,683 | 20,212 | Jul 02, 2020, 04:13 PM |
| O'Neil Thomas P. | Chief Financial Officer | Jun 23, 2020 | Option Exercise | $1.04 | 2,115 | 2,200 | 2,115 | Jun 24, 2020, 04:53 PM |
| O'Neil Thomas P. | Chief Financial Officer | Jun 23, 2020 | Sale | $35.23 | 2,115 | 74,512 | 0 | Jun 24, 2020, 04:53 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Jun 01, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 21,212 | Jun 02, 2020, 07:33 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Jun 01, 2020 | Sale | $25.26 | 1,000 | 25,257 | 20,212 | Jun 02, 2020, 07:33 PM |
| O'Neil Thomas P. | Chief Financial Officer | Jun 01, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 1,000 | Jun 02, 2020, 07:31 PM |
| O'Neil Thomas P. | Chief Financial Officer | Jun 01, 2020 | Sale | $25.32 | 1,000 | 25,323 | 0 | Jun 02, 2020, 07:31 PM |
| O'Neil Thomas P. | Chief Financial Officer | May 20, 2020 | Option Exercise | $4.56 | 2,000 | 9,120 | 2,000 | May 21, 2020, 05:34 PM |
| O'Neil Thomas P. | Chief Financial Officer | May 20, 2020 | Sale | $25.00 | 2,000 | 50,000 | 0 | May 21, 2020, 05:34 PM |
| ALBRECHT DETLEF | Chief Medical Officer | May 05, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 21,212 | May 06, 2020, 07:47 PM |
| ALBRECHT DETLEF | Chief Medical Officer | May 05, 2020 | Sale | $20.00 | 1,000 | 20,000 | 20,212 | May 06, 2020, 07:47 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Apr 14, 2020 | Option Exercise | $4.56 | 800 | 3,648 | 21,012 | May 06, 2020, 07:46 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Apr 14, 2020 | Sale | $20.00 | 800 | 16,000 | 20,212 | May 06, 2020, 07:46 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Apr 01, 2020 | Option Exercise | $4.56 | 200 | 912 | 20,412 | May 06, 2020, 07:45 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Apr 01, 2020 | Sale | $20.25 | 200 | 4,049 | 20,212 | May 06, 2020, 07:45 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Apr 14, 2020 | Option Exercise | $4.56 | 800 | 3,648 | 20,812 | Apr 16, 2020, 04:12 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Apr 14, 2020 | Sale | $20.00 | 800 | 16,000 | 20,012 | Apr 16, 2020, 04:12 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Apr 01, 2020 | Option Exercise | $4.56 | 200 | 912 | 20,412 | Apr 03, 2020, 04:11 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Apr 01, 2020 | Sale | $20.25 | 200 | 4,049 | 20,012 | Apr 03, 2020, 04:11 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Mar 11, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 21,212 | Mar 12, 2020, 05:32 PM |
| ALBRECHT DETLEF | Chief Medical Officer | Mar 11, 2020 | Sale | $27.42 | 1,000 | 27,422 | 20,212 | Mar 12, 2020, 05:32 PM |
| O'Neil Thomas P. | Chief Financial Officer | Mar 11, 2020 | Option Exercise | $4.56 | 1,000 | 4,560 | 1,000 | Mar 12, 2020, 05:31 PM |
| O'Neil Thomas P. | Chief Financial Officer | Mar 11, 2020 | Sale | $27.68 | 1,000 | 27,678 | 0 | Mar 12, 2020, 05:31 PM |
| TPG Group Holdings (SBS) Advisors, Inc. | 10% Owner | Sep 17, 2019 | Buy | $15.00 | 100,000 | 1,500,000 | 1,885,939 | Sep 18, 2019, 04:40 PM |
| RA CAPITAL MANAGEMENT, LLC | Director | Sep 17, 2019 | Buy | $15.00 | 1,333,333 | 19,999,995 | 4,681,858 | Sep 17, 2019, 05:04 PM |
| Shah Rajeev M. | Director | Sep 17, 2019 | Buy | $15.00 | 1,333,333 | 19,999,995 | 4,681,858 | Sep 17, 2019, 04:05 PM |
| TAKANASHI KEN | Director | Sep 17, 2019 | Buy | $15.00 | 233,333 | 3,499,995 | 1,561,719 | Sep 17, 2019, 04:05 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| COMMODORE CAPITAL LP | 10% Owner | 11/24/2021 | 15,837 |
| COMMODORE CAPITAL LP | 10% Owner | 11/22/2021 | 54,785 |
| COMMODORE CAPITAL LP | 10% Owner | 11/19/2021 | 17,544 |
| COMMODORE CAPITAL LP | 10% Owner | 11/11/2021 | 48,043 |
| COMMODORE CAPITAL LP | 10% Owner | 11/10/2021 | 56,289 |
| COMMODORE CAPITAL LP | 10% Owner | 11/08/2021 | 3,354 |
| COMMODORE CAPITAL LP | 10% Owner | 11/05/2021 | 46,410 |
| COMMODORE CAPITAL LP | 10% Owner | 11/04/2021 | 8,232 |
| COMMODORE CAPITAL LP | 10% Owner | 11/02/2021 | 50,083 |
| COMMODORE CAPITAL LP | 10% Owner | 10/29/2021 | 254,957 |
| COMMODORE CAPITAL LP | 10% Owner | 10/28/2021 | 83,705 |
| COMMODORE CAPITAL LP | 10% Owner | 10/27/2021 | 215,716 |
| COMMODORE CAPITAL LP | 10% Owner | 10/22/2021 | 152,236 |
| COMMODORE CAPITAL LP | 10% Owner | 10/21/2021 | 177,206 |
| COMMODORE CAPITAL LP | 10% Owner | 10/20/2021 | 221,207 |
| COMMODORE CAPITAL LP | 10% Owner | 10/19/2021 | 444,031 |
| COMMODORE CAPITAL LP | 10% Owner | 10/18/2021 | 176,265 |
| COMMODORE CAPITAL LP | 10% Owner | 10/15/2021 | 608,580 |
| RA CAPITAL MANAGEMENT, L.P. | Director | 02/26/2021 | 6,999,998 |
| ALBRECHT DETLEF | Chief Medical Officer | 09/01/2020 | 4,560 |
| ALBRECHT DETLEF | Chief Medical Officer | 09/01/2020 | 22,210 |
| O'Neil Thomas P. | Chief Financial Officer | 09/01/2020 | 3,420 |
| O'Neil Thomas P. | Chief Financial Officer | 09/01/2020 | 16,645 |
| O'Neil Thomas P. | Chief Financial Officer | 08/05/2020 | 4,560 |
| O'Neil Thomas P. | Chief Financial Officer | 08/05/2020 | 25,000 |
| ALBRECHT DETLEF | Chief Medical Officer | 08/03/2020 | 4,560 |
| ALBRECHT DETLEF | Chief Medical Officer | 08/03/2020 | 22,906 |
| O'Neil Thomas P. | Chief Financial Officer | 07/01/2020 | 4,560 |
| O'Neil Thomas P. | Chief Financial Officer | 07/01/2020 | 26,654 |
| ALBRECHT DETLEF | Chief Medical Officer | 07/01/2020 | 4,560 |
| ALBRECHT DETLEF | Chief Medical Officer | 07/01/2020 | 26,683 |
| O'Neil Thomas P. | Chief Financial Officer | 06/23/2020 | 2,200 |
| O'Neil Thomas P. | Chief Financial Officer | 06/23/2020 | 74,512 |
| ALBRECHT DETLEF | Chief Medical Officer | 06/01/2020 | 4,560 |
| ALBRECHT DETLEF | Chief Medical Officer | 06/01/2020 | 25,257 |
| O'Neil Thomas P. | Chief Financial Officer | 06/01/2020 | 4,560 |
| O'Neil Thomas P. | Chief Financial Officer | 06/01/2020 | 25,323 |
| O'Neil Thomas P. | Chief Financial Officer | 05/20/2020 | 9,120 |
| O'Neil Thomas P. | Chief Financial Officer | 05/20/2020 | 50,000 |
| ALBRECHT DETLEF | Chief Medical Officer | 05/05/2020 | 4,560 |
| ALBRECHT DETLEF | Chief Medical Officer | 05/05/2020 | 20,000 |
| ALBRECHT DETLEF | Chief Medical Officer | 04/14/2020 | 3,648 |
| ALBRECHT DETLEF | Chief Medical Officer | 04/14/2020 | 16,000 |
| ALBRECHT DETLEF | Chief Medical Officer | 04/01/2020 | 912 |
| ALBRECHT DETLEF | Chief Medical Officer | 04/01/2020 | 4,049 |
| ALBRECHT DETLEF | Chief Medical Officer | 04/14/2020 | 3,648 |
| ALBRECHT DETLEF | Chief Medical Officer | 04/14/2020 | 16,000 |
| ALBRECHT DETLEF | Chief Medical Officer | 04/01/2020 | 912 |
| ALBRECHT DETLEF | Chief Medical Officer | 04/01/2020 | 4,049 |
| ALBRECHT DETLEF | Chief Medical Officer | 03/11/2020 | 4,560 |
| ALBRECHT DETLEF | Chief Medical Officer | 03/11/2020 | 27,422 |
| O'Neil Thomas P. | Chief Financial Officer | 03/11/2020 | 4,560 |
| O'Neil Thomas P. | Chief Financial Officer | 03/11/2020 | 27,678 |
| TPG Group Holdings (SBS) Advisors, Inc. | 10% Owner | 09/17/2019 | 1,500,000 |
| RA CAPITAL MANAGEMENT, LLC | Director | 09/17/2019 | 19,999,995 |
| Shah Rajeev M. | Director | 09/17/2019 | 19,999,995 |
| TAKANASHI KEN | Director | 09/17/2019 | 3,499,995 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report: 12/31/2021
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2021
2.80%
1Q
06/30/2021
8.95%
2Q
03/31/2021
32.76%
3Q